Carna Biosciences Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Carna Biosciences Inc with three other
companies in this sector in Japan:
sales of 1.91 billion Japanese Yen [US$18.31 million]
of which 54%
was Cell Therapy Technology Development Busi),
Japan Tissue Engineering Company Limited
(1.32 billion Japanese Yen [US$12.67 million]
of which 93%
was Regenerative Medicine Products Business), and
Medinet Co., Ltd.
(1.67 billion Japanese Yen [US$16.06 million]
of which 100%
was cell processing).
Sales increased substantially in 2015:
During the year ended December of 2015, sales at
Carna Biosciences Inc were ¥1.57 billion (US$15.05 million).
increase of 156.5%
versus 2014, when the company's sales were ¥611.76 million.